Literature DB >> 2530385

Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses.

S J Schwab1, J R Raymond, M Saeed, G E Newman, P A Dennis, R R Bollinger.   

Abstract

Venous dialysis pressures were measured consecutively in 168 chronic hemodialysis patients for 265 patient-years of monitored dialysis. Venous dialysis pressure greater than 150 mm Hg measured by the protocol were considered elevated. Seventy-three patients had elevated venous dialysis pressures and 58 agreed to undergo elective venography (fistulogram). Fifty of 58 patients studied (86%) had significant venous stenoses. A combination of percutaneous transluminal angioplasty (PTA) and surgical revision were used to electively treat these stenoses. Early detection and treatment of these stenoses decreased fistula thrombosis and fistula replacement threefold compared with our earlier experiences. Patients with elevated venous dialysis pressure who were venogramed and treated had an occurrence of fistula thrombosis similar to patients with normal dialysis pressure (0.15 and 0.13 episodes per patient year of dialysis respectively, P = NS). In contrast patients with elevated venous dialysis pressure who refused elective fistulogram and treatment averaged 1.4 episodes of thrombosis per patient year of dialysis (P less than 0.001) compared to both other groups). We conclude that elevated venous dialysis pressure is a reliable method of detecting fistula stenoses and that the elective treatment of these stenoses significantly decreases fistula thrombosis and fistula loss.

Entities:  

Mesh:

Year:  1989        PMID: 2530385     DOI: 10.1038/ki.1989.250

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  26 in total

1.  The Role of Interventional Radiology in a Comprehensive Hemodialysis Program: The Access Surgeon's View.

Authors:  Daniel Katz
Journal:  Semin Intervent Radiol       Date:  2004-06       Impact factor: 1.513

Review 2.  Preserving function and long-term patency of dialysis access.

Authors:  J A Akoh; N S Hakim
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

3.  Unexpected restoration of an arteriovenous graft function: the significance of vascular access surveillance.

Authors:  Theodoros Eleftheriadis; Christos Rountas; Georgios Karagiorgas; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  CEN Case Rep       Date:  2020-03-10

4.  How is arteriovenous fistula longevity best prolonged?: The role of surveillance.

Authors:  Loay H Salman
Journal:  Semin Dial       Date:  2014-09-18       Impact factor: 3.455

Review 5.  Complications of the Arteriovenous Fistula: A Systematic Review.

Authors:  Ahmed A Al-Jaishi; Aiden R Liu; Charmaine E Lok; Joyce C Zhang; Louise M Moist
Journal:  J Am Soc Nephrol       Date:  2016-12-28       Impact factor: 10.121

Review 6.  Vascular access for hemodialysis: postoperative evaluation and function monitoring.

Authors:  Konstantinos Leivaditis; Stelios Panagoutsos; Athanasios Roumeliotis; Vassilios Liakopoulos; Vassilis Vargemezis
Journal:  Int Urol Nephrol       Date:  2013-09-18       Impact factor: 2.370

7.  Percutaneous transluminal angioplasty of malfunctioning Brescia-Cimino arteriovenous fistula: analysis of factors adversely affecting long-term patency.

Authors:  Koji Sugimoto; Takanori Higashino; Yoichiro Kuwata; Kazufumi Imanaka; Shozo Hirota; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2002-11-29       Impact factor: 5.315

Review 8.  Hemodialysis vascular access monitoring: current concepts.

Authors:  Michael Allon; Michelle L Robbin
Journal:  Hemodial Int       Date:  2009-04       Impact factor: 1.812

9.  Elbow fistulas using autogeneous vein: patency rates and results of revision.

Authors:  G J Murphy; R Saunders; M Metcalfe; M L Nicholson
Journal:  Postgrad Med J       Date:  2002-08       Impact factor: 2.401

10.  Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients.

Authors:  Franklin G Mora-Bravo; Alfonso Mariscal; Juan P Herrera-Felix; Salvador Magaña; Guadalupe De-La-Cruz; Nelly Flores; Laura Rosales; Martha Franco; Héctor Pérez-Grovas
Journal:  BMC Nephrol       Date:  2008-11-24       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.